In certain embodiments, this disclosure relates to methods of treating or preventing type 2 diabetes, pre-diabetes and conditions characterized by an increase in the levels of AIC, glucose, insulin, homeostasis model of assessment of insulin resistance (HOMA-IR), oxidative stress in adipose tissue, and earbonvlation of GLUT4 comprising administering an effective amount of a compound of Formula I-III as described herein, to a subject in need thereof.
在某些实施例中,本公开涉及治疗或预防2型糖尿病、糖尿病前期以及表现为AIC
水平增加、
葡萄糖、
胰岛素、
胰岛素抵抗的稳态模型(HOMA-IR)、脂肪组织氧化应激和GLUT4的碳化等情况的方法,包括向需要的受试者施用本文描述的I-III式化合物的有效量。